期刊
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
卷 153B, 期 1, 页码 220-228出版社
WILEY
DOI: 10.1002/ajmg.b.30980
关键词
Parkinson's disease; meta-analysis; genome-wide association
资金
- Inserm
- MSA
- Agence Nationale de la Recherche
- Agence Francaise de Securite Sanitaire de l'Environnement et du Travail
- France Parkinson
- FIRB [R-BLA038RMA_003]
- National Institutes of Health (NIH) [2R01 ES10751, ES10758, AG 08724]
- Michael J. Fox Grants
- Swedish Medical Research Council
- Swedish Society of Medicine
- Parkinson Foundation in Sweden
- VIB Genetic Service Facility
- Biobank of the Institute Born-Bunge
- Fund for Scientific Research Flanders
- Institute for Science and Technology - Flanders (IWT-V)
- Foundation for Alzheimer Research (SAO/FRMA)
- Belgian Science Policy Office, Belgium [P6/43]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007034] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010758, R01ES010751] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [R01AG008724] Funding Source: NIH RePORTER
Early genome-wide association (GWA) studies on Parkinson's disease (PD) have not been able to yield conclusive, replicable signals of association, perhaps due to limited sample size. We aimed to investigate whether association signals derived from the meta-analysis of the first two GWA investigations might be replicable in different populations. We examined six single-nucleotide polymorphisms (SNPs) (rs1000291, rs1865997, rs2241743, rs2282048, rs2313982, and rs3018626) that had reached nominal significance with at least two of three different strategies proposed in a previous analysis of the original GWA studies. Investigators from the Genetic Epidemiology of Parkinson's Disease (GEOPD) consortium were invited to join in this study. Ten teams contributed replication data from 3,458 PD cases and 3,719 controls. The data from the two previously published GWAs (599 PD cases, 592 controls and 443 sibling pairs) were considered as well. All data were synthesized using both fixed and random effects models. The summary allelic odds ratios were ranging from 0.97 to 1.09 by random effects, when all data were included. The summary estimates of the replication data sets (excluding the original GWA data) were very close to 1.00 (range 0.98-1.09) and none of the effects were nominally statistically significant. The replication data sets had significantly different results than the GWA data. Our data do not support evidence that any of these six SNPs reflect susceptibility markers for PD. Much stronger signals of statistical significance in GWA platforms are needed to have substantial chances of replication. Specifically in PD genetics, this would require much larger GWA studies and perhaps novel analytical techniques. (C) 2009 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据